Correlation between miR-23a and onset of hepatocellular carcinoma

Clinics and Research in Hepatology and Gastroenterology

Volumn 38, Issue 3, 2014, Pages 318-330

  Bao, Lidao ^a   Zhao, Jianfen ^b   Dai, Xiaoxia ^b   Wang, Yi ^a   Ma, Ruilian ^a   Su, Yila ^c   Cui, Hongwei ^c   Niu, Jianxiang ^d   Bai, Shiming ^e   Xiao, Zhiying ^f   Yuan, Hongwei ^d   Yang, Zhou ^a   Li, Changqing ^a   Cheng, Rui ^a   Ren, Xianhua ^a  

^a AFFILIATED HOSPITAL OF INNER MONGOLIA MEDICAL UNIVERSITY   (China)

^b Binzhou People's Hospital   (China)

^c Molecular Biotechnology Center of Inner Mongolia Medical University   (China)

^d INNER MONGOLIA MEDICAL UNIVERSITY   (China)

^e KITAMI INSTITUTE OF TECHNOLOGY   (Japan)

^f INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 23A; UNCLASSIFIED DRUG; ALPHA FETOPROTEIN; MIRN23 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CELL GROWTH; GENE EXPRESSION; GENE SEQUENCE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MIDDLE AGED; OVERALL SURVIVAL; PREDICTION; RECURRENCE FREE SURVIVAL; TUMOR CELL LINE; TUMOR VOLUME; UPREGULATION; VERY ELDERLY; APOPTOSIS; CELL LINE; DOWN REGULATION; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; LIVER; LIVER TUMOR; MALE; METABOLISM; PATHOLOGY; PRECANCER; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; TUMOR INVASION;

AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE; DOWN-REGULATION; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; UP-REGULATION;

EID: 84902545532     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2013.12.002     Document Type: Article

References (39)

1. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of microRNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002, 99:15524-15529.
2. Wong K.Y., Yu L., Chim C.S. DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family. Epigenomics 2011, 3:83-92.
3. Hirata H., Ueno K., Shahryari V., Tanaka Y., Tabatabai Z.L., Hinoda Y., et al. Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS One 2012, 7:e51056.
4. Huang S., He X., Ding J., Liang L., Zhao Y., Zhang Z., et al. Up-regulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer 2008, 123:972-978.
5. Wang N., et al. MiR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma. Mol Cancer 2013, 12:119.
6. Wang B., et al. Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha. Hepatology 2012, 56:186-197.
7. Zhu M., et al. Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract. Exp Ther Med 2011, 2:27-32.
8. Takata A., Otsuka M., Yoshikawa T., Kishikawa T., Kudo Y., Goto T., et al. A miRNA machinery component DDX20 controls NF-kappaB via microRNA-140 function. Biochem Biophys Res Commun 2012, 420:564-569.
9. Karakatsanis A., Papaconstantinou I., Gazouli M., Lyberopoulou A., Polymeneas G., Voros D. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 2013, 52:297-303.
10. Scisciani C., Vossio S., Guerrieri F., Schinzari V., De Iaco R., D'Onorio de Meo P., et al. Transcriptional regulation of miR-224 up-regulated in human HCCs by NF-kappaB inflammatory pathways. J Hepatol 2012, 56:855-861.
11. Kim J.E., Lee J.Y., Kim Y.J., Yoon J.H., Kim S.H., Lee J.M., et al. Acoustic radiation force impulse elastography for chronic liver disease: comparison with ultrasound-based scores of experienced radiologists, Child-Pugh scores and liver function tests. Ultrasound Med Biol 2010, 36:1637-1643.
12. Kang M.K., Kim M.S., Kim S.K., Ye G.W., Lee H.J., Kim T.N., et al. High-dose radiotherapy with intensity-modulated radiation therapy for advanced hepatocellular carcinoma. Tumori 2011, 97:724-731.
13. Zhou L., Rui J.A., Wang S.B., Chen S.G., Qu Q. Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2013, 12:68-73.
14. Zhang Y., Deng Z.S., Liao M.M., Wang N., Zhang X.Q., Yu H.Y., et al. Tumor associated glycoprotein-72 is a novel marker for poor survival in hepatocellular carcinoma. Pathol Oncol Res 2012, 18:911-916.
15. Marchetti D., Spagnolo A., Cicerone M., Cascini F., La Monaca G., Spagnolo A.G. Research Ethics Committee Auditing: The Experience of a University Hospital 2013, HEC Forum.
16. Liu H., Wang Y., Li X., Zhang Y.J., Li J., Zheng Y.Q., et al. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1. Tumour Biol 2013, 34:1713-1722.
17. Castagnino P., Kothapalli D., Hawthorne E.A., Liu S.L., Xu T., Rao S., et al. miR-221/222 compensates for Skp2-mediated p27 degradation and is a primary target of cell cycle regulation by prostacyclin and cAMP. PLoS One 2013, 8:e56140.
18. Luo J., Chen M., Huang H., Yuan T., Zhang M., Zhang K., et al. Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma. Onco Targets Ther 2013, 6:577-583.
19. Yi Z., Fu Y., Zhao S., Zhang X., Ma C. Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. J Cancer Res Clin Oncol 2010, 136:855-862.
20. Christensen L.L., Tobiasen H., Holm A., Schepeler T., Ostenfeld M.S., Thorsen K., et al. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer. Int J Cancer 2013, 133:67-78.
21. Neagoe I.B., Braicu C., Matea C., Bele C., Florin G., Gabriel K., et al. Efficient siRNA delivery system using carboxilated single-wall carbon nanotubes in cancer treatment. J Biomed Nanotechnol 2012, 8:567-574.
22. Gong C., Tao G., Yang L., Liu J., He H., Zhuang Z. The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells. Mol Biol Rep 2012, 39:4915-4925.
23. Rastogi A., Luo Z., Wu Z., Ho P.S., Bowman P.D., Stavchansky S. Development and characterization of a scalable microperforated device capable of long-term zero order drug release. Biomed Microdevices 2010, 12:915-921.
24. Nahata A., Saxena A., Suri N., Saxena A.K., Dixit V.K. Sphaeranthus indicus induces apoptosis through mitochondrial-dependent pathway in HL-60 cells and exerts cytotoxic potential on several human cancer cell lines. Integr Cancer Ther 2013, 12:236-247.
25. Han H., Peng J., Gobert G.N., Hong Y., Zhang M., Han Y., et al. Apoptosis phenomenon in the schistosomulum and adult worm life cycle stages of Schistosoma japonicum. Parasitol Int 2013, 62:100-108.
26. Zha T.Z., Hu B.S., Yu H.F., Tan Y.F., Zhang Y., Zhang K. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma. Tumour Biol 2012, 33:2125-2134.
27. Bronevetsky Y., Villarino A.V., Eisley C.J., Barbeau R., Barczak A.J., Heinz G.A., et al. T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire. J Exp Med 2013, 210:417-432.
28. Zhang Q.X., Lu R.W., Curcio C.A., Yao X.C. In vivo confocal intrinsic optical signal identification of localized retinal dysfunction. Invest Ophthalmol Vis Sci 2012, 53:8139-8145.
29. Li H.S., Greeley N., Sugimoto N., Liu Y.J., Watowich S.S. miR-22 controls Irf8 mRNA abundance and murine dendritic cell development. PLoS One 2012, 7:e52341.
30. Garofalo M., Di Leva G., Romano G., Nuovo G., Suh S.S., Ngankeu A., et al. miR-221 & 222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 down-regulation. Cancer Cell 2009, 16:498-509.
31. Zhi Q., Zhu J., Guo X., He S., Xue X., Zhou J., et al. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage. Biomed Pharmacother 2013, 67:393-398.
32. Katayama Y., Maeda M., Miyaguchi K., Nemoto S., Yasen M., Tanaka S., et al. Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling. Oncol Lett 2012, 4:817-823.
33. Xia H., Ooi L.L., Hui K.M. MiR-214 targets beta-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS One 2012, 7:e44206.
34. Troisi R.I., Van Huysse J., Berrevoet F., Vandenbossche B., Sainz-Barriga M., Vinci A., et al. Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation. Surg Endosc 2011, 25:79-87.
35. Zhong X.Y., Yu J.H., Zhang W.G., Wang Z.D., Dong Q., Tai S., et al. MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene 2012, 493:44-51.
36. Yang X., Yin J., Yu J., Xiang Q., Liu Y., Tang S., et al. miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w. Oncol Rep 2012, 27:250-257.
37. Li X., Li J., Jiang G., Bu L., Yang F., Liu J., et al. Influence on the behavior of lung cancer H1299 cells by silencing SLC35F2 expression. Cancer Cell Int 2013, 13:73.
38. Xiong W., Sun L.P., Chen X.M., Li H.Y., Huang S.A., Jie S.H. Comparison of microRNA expression profiles in HCC-derived microvesicles and the parental cells and evaluation of their roles in HCC. J Huazhong Univ Sci Technolog Med Sci 2013, 33:346-352.
39. Zhang Y., Takahashi S., Tasaka A., Yoshima T., Ochi H., Chayama K. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma. J Gastroenterol Hepatol 2013, 28:565-575.